论文信息 - Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma. - 字舞流文

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma.

W. Rathmell | E. Jonasch | E. Plimack | M. Milowsky | B. Rini | R. Slack | D. Geynisman | N. Tannir | M. Ornstein | E. Hasanov | S. Stovall | D. Juarez | Troy R Gilchrist | Lisa Pruitt